About Us

BioInitials, founded in April 2019, develops non-invasive medical devices to monitor the health-state of the oral cavity. Based on biochemical sensors we evaluate saliva biomarkers to identify risk factors related to periodontitis.

Our goal is to increase the degree of oral health among the general population, to prevent periodontitis disease progression and to consequently reducing the costs of treatment by early detection of disease onset.

Periodontitis is a significant public health problem with prevalence higher than 50%.
In the USA and in Europe alone, the disease affects more than 220 million patients.